Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocular Therapeutix (OCUL) Other Operating Expenses: 2012-2024

Historic Other Operating Expenses for Ocular Therapeutix (OCUL) over the last 13 years, with Dec 2024 value amounting to $47.2 million.

  • Ocular Therapeutix's Other Operating Expenses rose 22.48% to $14.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.0 million, marking a year-over-year increase of 26.73%. This contributed to the annual value of $47.2 million for FY2024, which is 3.02% up from last year.
  • According to the latest figures from FY2024, Ocular Therapeutix's Other Operating Expenses is $47.2 million, which was up 3.02% from $45.8 million recorded in FY2023.
  • In the past 5 years, Ocular Therapeutix's Other Operating Expenses ranged from a high of $47.2 million in FY2024 and a low of $28.7 million during FY2020.
  • For the 3-year period, Ocular Therapeutix's Other Operating Expenses averaged around $45.8 million, with its median value being $45.8 million (2023).
  • Data for Ocular Therapeutix's Other Operating Expenses shows a peak YoY skyrocketed of 37.98% (in 2021) over the last 5 years.
  • Over the past 5 years, Ocular Therapeutix's Other Operating Expenses (Yearly) stood at $28.7 million in 2020, then skyrocketed by 37.98% to $39.6 million in 2021, then increased by 12.29% to $44.5 million in 2022, then increased by 3.08% to $45.8 million in 2023, then rose by 3.02% to $47.2 million in 2024.